Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) are often the initial treatment for rheumatoid arthritis. NSAID-induced inhibition of cyclooxygenase-2 (COX2) and cyclooxygenase-1 appears to correlate with clinical efficacy and toxicity, respectively. Newer NSAIDs with greater COX2 selectivity offer the promise of less toxic therapy.
Similar content being viewed by others
References
McDuffie FC. Morbidity impact of rheumatoid arthritis on society.Am J Med. 1985;78(suppl 1A):1–5.
Markenson JA. Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis.Semin Arthritis Rheum. 1991;21(suppl 1):4–12.
Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.Arthritis Rheum. 1990;33:305–315.
Fremont-Smith K, Bayles TB. Salicylate therapy in rheumatoid arthritis.JAMA. 1965;192:1133–1136.
Heller CA, Ingelfinger JA, Goldman P. Nonsteroidal antiinflammatory drugs and aspirin: Analyzing the scores.Pharmacotherapy. 1985;5:30–38.
Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs: differences and similarities.N Engl J Med. 1991;324:1716–1725.
Dewitt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression.Biochim Biophys Acta. 1991;1083:121–134.
Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs.Scand J Rheumatol. 1996;25(suppl 102):9–21.
Crofford LJ, Wilder RL, Ristimaki AP, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues.J Clin Invest. 1994;93:1095–1101.
Tomlinson A, Appleton I, Moore AR, et al. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy.Br J Pharmacol. 1994;113:693–98.
Nogawa, S, Zhang R, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.J Neursci. 1997;17:2746–2755.
Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.J Clin Invest. 1994;94:2504–2510.
Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and altered inflammatory response in mice lacking cyclooxygenase II.Nature. 1995;378:406–407.
Slater DM, Bryer LC, Newton R, Moore GE, Bennett PR. Expression of cyclooxygenase type 1 and type 2 in human fetal membranes at term.Am J Obstet Gynecol. 1995;172(1):77–82.
Eberhart CE, Coffey RJ, Radhika A, et al. Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.Gastroenterology. 1994;107:1183–1188.
Williams HJ, Ward JR, Marlene JE, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee.Arthritis Rheum. 1993;36:1196–1206.
Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers.Am J Gastroenterol. 1998;93:2037–2046.
Polisson R. Nonsteroidal anti-inflammatory drugs: Practical and theoretical considerations in their selection.Am J Med. 1996;100(suppl 2A)31s-36s.
Clive DM, Stoff SS. Renal syndromes associated with nonsteroidal antiinflammatory drugs.N Engl J Med. 1984;310:563–572.
Spangler RS. Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy.Semin Arthritis Rheum. 1996;26:435–446.
Vane J. Differential inhibition of cyclooxygenase isoforms: an explanation of the actions of NSAIDs.J Clin Rheumatol. 1998;4(5):s3-s10.
Mitchell JA, Adarasereenont P, Themermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.Proc Natl Acad Sci USA. 1994;90:11693–11697.
Meade EA, Smith WL, Dewitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.J Biol Chem. 1993;268:3310–3314.
Distal M, Mueller C, Bluhmki E, Fries J. Safety of meloxican: a global analysis of clinical trials.Br J Rheumatol. 1996;35(suppl 1):68–77.
Barner A. Review of clinical trials and benefit/risk ratio of meloxicam.Scand J Rheumatol. 1996;102(suppl):29–37.
Furst DE. Meloxicam: selective COX-2 inhibition in clinical practice.Semin Arthritis Rheum. 1997;26(suppl 1):21–27.
Freed MI, Audet PA, Zariffa N, et al. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers.J Clin Pharmacol. 1994;34:1098–1108.
Author information
Authors and Affiliations
About this article
Cite this article
Daoud, K.F., Jackson, C.G. & Williams, H.J. Basic therapy for rheumatoid arthritis: Nonsteroidal anti-inflammatory drugs. Compr Ther 25, 427–433 (1999). https://doi.org/10.1007/BF02944294
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02944294